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Abstract 
Background and Purpose: To investigate the geometrical accuracy in 
proton beam therapy (PBT) to the lung by comparing the location of the 
fibrosis after PBT and the tumor using less invasive method. 
Patients and Methods: We examined 50 lung tumors that had been treated 
by respiratory-gated PBT (33 – 74 Gray equivalents). Image registration 
and re-slicing of computed tomography (CT) before and after PBT were 
performed using an image analysis software system. We investigated 
whether the location of fibrosis was accurate with the tumor site and which 
factor among the respiratory rhythm, tumor volume, location, fixation, 
beam direction and clinical outcome was affected with accuracy. 
Results: The area of fibrosis was accurate with the tumor in 45 tumors 
(Group A) and not accurate in 5 tumors (Group B). All lesions with a small 
irregularity of respiratory rhythm showed fibrosis in an area accurate with 
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the tumor. This percentage (100%) was higher than that of the lesions with 
a large irregularity of respiratory rhythm (67%, p=0.037). Radiation 
pneumonitis was found for 1 lesion in group A and 2 lesions in group B 
(p=0.0009). 
Conclusion: The geometrical accuracy of beam delivery to the lung was 
higher in the patients with a regular respiratory rhythm in PBT. The 
patients of group B had greater risk of pneumonitis. 
 
Key words: proton beam therapy, lung tumor, respiratory-gated therapy, 
fibrosis, CT, geometrical accuracy 
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Introduction 
To increase the precision of radiotherapy, reducing geometric uncertainties, 
induced by interfraction setup variations and intrafraction breathing 
movements, is essential as these can lead to differences between the 
planned dose distribution and the actually delivered radiation dose.  
A variety of methods have been reported for monitoring the 
interfraction setup variation, including the isocenter dose reproducibility 
[1], repeated radiographs [2], and repeated CT examinations [3]. A variety 
of methods have also been reported for monitoring intrafraction breathing 
movements, including electronic portal images [2], fluoroscopy [4], tumor 
movement from CT [5], dose-volume histograms [6], and the calculation of 
the geometric error based on respiratory motion data [7]. Moreover, not 
only interfraction setup variations and intrafraction breathing movements 
can alter the dose distribution, but also the changes in Hounsfield units 
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(HU) during breathing [8], mechanical response delays [7], and tumor 
volume changes during the treatment course. Hence, the accuracy of the 
dose delivery is too complex to be confirmed or predicted based solely on 
an evaluation of the setup or breathing-related movements of the lung 
tumor. To our knowledge, a radiographic investigation of the geometric 
accuracy of irradiation to lung tumors using an image registration 
technique has not been previously reported. 
Fibrosis on CT images occur following lung irradiation. In proton 
beam therapy (PBT), the proton beam allows a rapidly increasing dose at 
the end of the beam range [9]. PBT is clinically used in some kind of tumor 
treatment utilizing its physical and biological characteristics [10-13]. 
Excellent dose localization of the proton beam causes a localized fibrosis in 
and surrounding the tumor after irradiation. Images obtained after 
radiotherapy show the final effect after all factors affecting geometric 
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accuracy have been applied. Thus, the fibrosis has potential to evaluate real 
geometrical accuracy that is not achievable by investigating individual 
factors.  
The aim of this study was to investigate the accuracy of proton 
beam delivery and depth to the lung by examining the locations of fibrosis 
and the tumor using an image analysis software system. 
 
Material and Methods 
We analyzed data for 50 lung tumor lesions from 48 patients (median: 69.5 
years old [range, 46 – 84 years]; 36 men, 12 women) who underwent PBT 
between January 2004 and June 2010 at the University of Tsukuba and 
were followed up with a chest computed tomography (CT) examination 
after PBT. The diagnosis was lung cancer in 41 lesions, metastatic lung 
tumor in 8 lesions, and plasmacytoma in 1 lesion. 
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The selection criteria included lesions with a constant irradiation 
field and any field size or beam direction that was not changed during the 
course of treatment. Lesions with mild to moderate fibrosis (slight 
homogeneous increase in radiographic density or patchy consolidation) on 
follow-up chest CT examinations were selected and lesions with 
undetectable fibrosis, severe fibrosis (confluent consolidation) or severe 
distortion of the lung field arising from large quantities of pleural effusion 
or adhesions on follow-up chest CT examinations were excluded because 
image comparisons in such cases were thought to be unreliable. 
A treatment planning CT examination was performed one week 
before PBT. The chest CT scan was performed using a respiratory-gated 
acquisition protocol. The respiratory waveform was obtained from a laser 
displacement sensor (LDS) that could be focused on an area around the 
patient’s navel. A gate signal was given to enable exposure once the 
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respiratory waveform dropped below a certain threshold. The start of 
exposure was triggered by the gate signal at the end of exhalation phase 
(Figure 1). To achieve this gating, the CT table was moved to the next slice 
position after scanning. All the slices (5 mm thick) were scanned 
downwards from the top of the diaphragm. The pitch was 5 mm. 
The clinical target volume (CTV) was contoured as the gross 
tumor volume (GTV) plus a 5 – 10-mm margin on serial CT images. An 
additional 5-mm margin in the inferior direction was added to the CTV as 
an internal margin for respiratory movement. The planning target volume 
was defined as an internal target volume plus a 5 – 10-mm margin (5 mm: 
7 lesions, 7 mm: 12 lesions, 8 mm: 14 lesions, 10 mm: 17 lesions) in all 
directions. 
 Proton beams of 155 – 250 MeV were generated using a 
synchrotron accelerator at the Proton Medical Research Center, University 
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of Tsukuba. The beams were delivered under respiratory gating through 
one to four ports using a rotational gantry. During each treatment session, 
the position was examined using an orthogonal fluoroscopy unit attached to 
the treatment unit. The dose distribution was calculated using a pencil 
beam algorithm. The beam delivery devices were selected automatically by 
the treatment-planning system. A collimator was produced using a brass 
array. A range-compensating bolus was fabricated with a tissue-equivalent 
material. The beam delivery system created a homogeneous dose 
distribution at the prescription dose using the spread-out Bragg peak of the 
proton beams. The irradiation dose was 33 – 74 (median: 66) Gray 
equivalent (GyE) over 8 – 35 fractions. The fractionation varied according 
to the tumor location and the general condition of the patient. 
A chest CT examination for diagnosis was performed within 1 
month before and 4 – 20 (median: 12) months after PBT (CT [pre], CT 
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[post], respectively). The chest CT scans were obtained using a breath-hold 
acquisition protocol. A slice thickness of 5 mm with a slice interval of 5 
mm was used.  
The image analysis was performed using the Dr. View/LINUX 
image analysis software system (AJS Inc., Tokyo, Japan).  
We performed image registration of the CT (post) image using the 
CT (pre) image as a reference, both were obtained using a breath-hold 
acquisition protocol. For the image registration, we set 7 matching points 
(tracheal bifurcation, bifurcation of bilateral main bronchi, upper and lower 
thoracic spine, and bilateral sternoclavicular joints) on both the CT (pre) 
and CT (post) images for image registration. Next, we used a 
three-dimensional rigid registration using marker fitting and the least 
squares method; in this manner, the CT (post) image was 
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three-dimensionally registered and re-sliced at the same position relative to 
the CT (pre) image. 
We investigated accuracy of the fibrosis and the tumor. We 
defined accurate as fibrosis of re-sliced CT (post) overlap at least partially 
with the tumor of CT (pre) in their fusion image and not accurate as normal 
lung field aeration found between fibrosis and the tumor in all slice. We 
then examined the relevance of fibrosis-tumor accuracy and the respiratory 
rhythm, tumor volume, location, fixation, beam direction and clinical 
outcome. 
 
Data analysis and statistics 
Firstly, we examined the ratio that location of fibrosis in CT (post) was 
accurate or not with the tumor in CT (pre). We used lung window in CT 
(pre) to delineate the tumor. CT (pre) which was performed using a 
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breath-hold acquisition protocol was different from treatment planning CT 
performed using a respiratory-gated acquisition protocol. However, tumor 
delineation in CT (pre) almost corresponds to GTV in the treatment 
planning CT. Each lesion was classified according to whether the fibrosis 
was accurate (Group A) or not accurate (Group B) with the actual tumor. 
Lesions for which the fibrosis was accurate at least partially with the tumor 
were included in Group A, and only lesions for which the fibrosis was not 
completely overlapped with the tumor and normal lung field aeration was 
found between fibrosis and the tumor were included in Group B. 
Next, we investigated the relevance of the respiratory rhythm, 
tumor volume, tumor location, tumor fixation, and beam direction on the 
ratio of tumor and fibrosis accuracy. In the analysis of the respiratory 
rhythm, we randomly selected respiratory waveforms during 25 proton 
beam exposures and measured each beam cycle as the interval from one 
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beam to the next beam (Figure 1). The value of 25 set of beam cycle was 
converted into the percent normalization and then we calculated the 90% 
confidence intervals of the percent normalization of the beam cycle (90% 
B.C.) as a scale for respiratory rhythm irregularity. The tumor volume was 
classified as large and small, based on the CTV. The tumor location was 
classified as upper or lower, with the major fissure as the boundary line. 
The tumor fixation was classified as fixed to or free from a rigid structure, 
such as the aorta, vertebra, or chest wall. Finally, the beam direction was 
classified as anterior or posterior according to the most prominent side of 
dose delivery. The Fisher exact probability test was used to compare the 
significance of the ratios of tumor and fibrosis accuracy to the classification 
of the 90% B.C., tumor volume, tumor location, tumor fixation and beam 
direction. We decided on cut-off values that was clear-cut and enabled 
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well-balanced numbers of patients in the classifications for 90% B.C. and 
tumor volume. 
Finally, we investigated the relevance of clinical follow-up data on 
the tumor and fibrosis accuracy. The local control rate and probability of 
radiation pneumonitis with a severity of more than Grade 3 (Radiation 
Therapy Oncology Group’s radiation morbidity scoring criteria) [14] as 
calculated using the Kaplan-Meier method, and a log-rank test was 
performed to compare Group A and B. A value of p < 0.05 was considered 
significant. 
  
Results 
Group A contained 45 lesions, while Group B contained 5. In Group B, the 
fibrosis was located in antero-medial, postero-caudal, medial, 
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medial-cranial, and medial-caudal directions from the tumor, respectively. 
All 5 patients of group B was received 66GyE. 
The value of the 90% B.C. was calculated for 25 lesions that 
were evaluated after the start of respiratory data recording (August 2006). 
The median value of the 90% B.C. was 21.8% (range, 1.7 – 63.8%) for all 
the lesions. Among the 16 lesions with a 90% B.C. ≤ 25%, all the lesions 
were classified in group A, while among the 9 lesions with a 90% B.C. > 
25%, 6 lesions were classified in group A and 3 lesions were classified in 
group B (p=0.037, Table 1). 
Twenty-eight lesions were located in the upper lobe of the lung, 
while 22 lesions were located in the lower lobe. Ten lesions were fixed to a 
rigid structure, and 40 lesions were free from the surrounding structures. 
The median CTV was 18.1 cm3 (range, 2 – 445 cm3) for all the lesions. 
Twenty-seven lesions had a volume ≤ 20 cm 3, and 23 had a volume > 20 
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cm3. The beam direction was predominantly anterior for the treatment of 15 
lesions and predominantly posterior for the treatment of 16 lesions. The 
remaining 19 lesions were irradiated equally from the anterior and posterior. 
No significant difference in the tumor location, tumor fixation, tumor 
volume, or beam direction was found between the two groups (Table 1). 
In group A, local recurrences were found for 5 lesions at 3, 11, 
12, 24 and 28 months after irradiation, respectively (median observation 
period for group A, 25 months [range, 3 – 80 months]), and the local 
control rate was 84.3% at 5 years. In group B, a local recurrence was found 
for 1 lesion at 16 months after irradiation (median observation period for 
Group B, 48 months [range, 7 – 83 months]), and the local control rate was 
75.0% at 5 years. No significant difference in the local control rates was 
observed between the two groups (p=0.646). In Group A, one lesion was 
associated with Grade 3 pneumonitis at 1 month, yielding an event 
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probability rate of 2.2% at 3 years. In Group B, two lesions were associated 
with Grade 3 pneumonitis at 5 and 6 months, respectively, yielding an 
event probability rate of 40% at 3 years. The event probability rate was 
significantly higher in Group B (p=0.0009). 
In a limited analysis of 41 lung cancer lesions, local recurrences 
were found for 4 lesions at 11, 12, 24 and 28 months after irradiation, 
respectively (median observation period for group A, 26 months [range, 4 – 
80 months]), and the local control rate was 84.0% at 5 years. In group B, a 
local recurrence was not found after irradiation (median observation period 
for Group B, 60 months [range, 48 – 83 months]). No significant difference 
in the local control rates was observed between the two groups (p=0.477). 
         Figures 2 and 3 shows the CT (pre), registered CT (post), and 
dose distribution images for representative lesions in Groups A and B, 
respectively. 
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Discussion 
This study evaluated whether an adequate irradiation dose was actually 
delivered to the tumor based on the fibrosis in the lung field. To the best of 
our knowledge, this is the first study to investigate the accuracy of the 
actual proton beam delivery in a non-invasive manner in the lung. 
As shown in the present results, patients with a large 90% B.C. had 
an increased risk of geometric error. In our system, the proton beam 
delivery is required for 0.3 seconds after the respiratory waveform drops 
below a threshold value and proton beam is delivered at most 0.3 seconds. 
However, the proton beam is not always delivered during a constant 
respiratory phase. In particular, irregular dropping of the respiratory 
waveform below the threshold can vary the phase of the proton beam 
delivery and the beam cycle. Moreover, some patients do not have an 
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adequate respiratory rhythm for respiratory-gated irradiation. Respiratory 
movement affects the target volume difference and the dose convolution, 
and patients with an irregular respiratory rhythm have a risk of geometrical 
inaccuracy during radiotherapy [7, 15]. In our previous study examining 
liver tumor patients, the 90% B.C. value was the only factor that 
determined the geometrical accuracy [16]. We used the same cut-off value 
(25%) in the present study for the reason the value is close to the mean 
value and adequate for group classification. The results of this study were 
quite similar and reproducible, compared with the results of liver tumor 
patients. Despite the popularity of respiratory-gated radiotherapy, 
geometrical errors may still occur in patients with an extremely irregular 
respiratory rhythm. Taken together, these results show that a large variation 
in the beam cycle causes geometric uncertainties, and lung tumor patients 
with extremely irregular respiratory rhythms should be encouraged to 
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perform regular respiration. Some kinds of device have been developed for 
regulation of respiratory rhythm. The education of patients with regard to 
achieving a stable and suitable respiratory rhythm could increase the 
geometrical dose delivery. The patients who have difficulty to perform 
regulation of respiratory rhythm should be treated using a larger margin or 
an alternative technique. Tumor movement and variations in tumor 
movement are known to be much larger in the superior-inferior direction 
than in the anterior-posterior or left-right directions [6, 17, 18]. In this 
study, no obvious trend was found in the locations of the fibrosis and the 
tumors, partly because of the small number of lesions in Group B. All 
patients of Group B was received 66 GyE as mentioned in Results section. 
In this study, most of patients (58%) received 66 GyE, followed by 72.6 
GyE (22%) and only patients who showed radiation fibrosis were selected. 
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Thus, investigation of radiation dose affecting severity or detectability of 
fibrosis by CT was not performed. 
The lung exhibits respiratory-induced flexibility, and lung tumors 
move differently, depending upon their location. Using fluoroscopy, 
Seppenwoolde et al. clearly demonstrated that tumors located in the lower 
lobe without attachment to a rigid structure moved with a large motion 
amplitude (12 ± 2 mm) in the cranial-caudal direction [17]. Minohara et al. 
reported interesting data indicating that the water-equivalent path length of 
the posterior side varied to a much larger extent than that of anterior side 
during the respiratory cycle, and this variation led to uncertainties in the 
range end of the particle beam [8]. In the present study, however, the 
geometric accuracy of the proton beam delivery and depth was unaffected 
by the tumor volume, location, fixation, or beam direction. 
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 As shown in the results, no significant difference in the local 
control rate was found between the lesions in group A and those in group B. 
The reason for this finding is difficult to explain for small sample size of 
group B. Diverse pathology and stage further make complication of data 
interpretation. However, in our previous study, the local control rate was 
97.0% at 2 years in patients with stage I non-small-cell lung cancer [19], 
and 11.4% of the patients with stage II or stage III non-small-cell lung 
cancer developed local recurrences during a median 16-month observation 
period [20]. This high local control rate may make it difficult to draw a 
definitive conclusion. 
As shown in the probability of event results, the lesions in Group B 
were associated with a high risk of radiation pneumonitis. It is hard to 
explain the reason. The tumor volumes of the two lesions associated with 
radiation pneumonitis in Group B were not very large (35 and 9.1 cm3, 
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respectively). In respiratory function, both patients exhibited mild 
restrictive ventilatory impairment (%VC=77.2 and 71.4%, respectively). 
We suspect that some kind of underlying disease in the lung, such as lung 
fibrosis, may have caused the irregular respiratory rhythm, and a larger 
number of patients with an underlying disease that caused irregular 
respiratory rhythm have been included in Group B. However, limited 
number of events has limitation of detailed comparative study. Further 
investigation of a larger number of patients is needed to elucidate this 
point. 
In recent years, an autoactivation study examined the geometrical 
accuracy in PBT [21]. This autoactivation study is probably the only 
published method of verifying the area of proton beam irradiation visually. 
This method produces a clear and easily understandable image. However, 
because the images of activated 11C that is mainly activated after proton 
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beam irradiation are made using a PET camera, an expensive capital 
investment is needed. Moreover, because the half-life of 11C is only 20 min, 
it is not suitable for verifying irradiation using multi-ports. In addition, the 
image resolution of PET images is not necessarily suitable for verifying the 
accuracy of irradiation. We compared CT before and after PBT using rigid 
registration technique. Rigid registration is simple and widely used 
technique. In spite of fibrosis and tumor shrinkage cause deformity of lung 
field, the deformity was quite small because we selected the image of 
approximate 1 year after treatment and excluded the case with large 
deformity. We consider that the presently reported method comparing the 
the actual tumor’s location and the fibrosis after irradiation using CT and 
an image registration technique may be useful for solving these problems. 
  
Conclusion 
26 
 
Large variation in beam intervals cause geometric uncertainties, and 
patients with extremely irregular respiratory rhythms might require 
education regarding respiration or should be treated using a larger margin 
or an alternative technique. 
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Figure legends 
Figure 1 
Time chart of respiratory-gated Proton beam therapy. 
(a) Respiratory waveform.  
(b) Threshold level of gating.  
(c) Timing of proton beam exposure.  
(d) Gate signal.  
The proton beam is delivered 0.3 seconds after the waveform drops below 
the threshold for 0.3 seconds.  
 
Figure 2 
A 76-year-old man with lung cancer in the left lung. The images show the 
CT (pre) (top), registered CT (post) (middle), and dose distribution 
(bottom). Each image shows the axial, coronal, and sagittal views from left 
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to right. Fibrosis was located surrounding the tumor. The 90% confidence 
intervals of the percent normalization of the beam cycle (90% B.C.) value 
was 7.09%. 
 
Figure 3 
A 46-year-old woman with a metastatic lung tumor in the right lung. The 
fibrosis was located on the antero-medial side of the tumor. The 90% B.C. 
value was 44.38%. 
 
 
0500
0 2 4 6 8 10
Time (sec)
R
el
at
iv
e 
vo
lta
ge
(a)
(c)
(d)
(b)
0.3 sec
0.3 sec
Beam cycle
Fig 1
Fig 2
Fig 3
90% B.C. 
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1
0.037 (n=25)
> 0.999 (n=50)
> 0.999 (n=50)
0.569 (n= 50)
0.600 (n= 31)
Group A Group B P value
Group A: fibrosis overlap with the tumor
Group B: fibrosis not overlap with the tumor
Table 1  Tumor and fibrosis consistency in each classification  
